Chemomab Therapeutics Ltd. Stock Analysis & AI Score
Chemomab Therapeutics Ltd. (CMMB) has an ST Score of 47.4 (C+), driven by its Momentum (A-) and held back by its Profitability (D). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Chemomab Therapeutics Ltd. (CMMB) has an ST Score of 47.4 (C+), driven by its Momentum (A-) and held back by its Profitability (D). Analysts rate it Buy.
- Strongest
- MomentumA-
- Weakest
- ProfitabilityD
All factor grades
- MomentumA-
- Financial StrengthB+
- ValuationB
- GrowthB
- ProfitabilityD
- Piotroski0/9
Contact
CMMB stock: frequently asked questions
What is CMMB's ST Score?
Chemomab Therapeutics Ltd. (CMMB) has an ST Score of 47.4 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CMMB a buy, hold, or sell?
Analysts rate CMMB a Buy. Our ST Score grades it C+ (47.4/100). The ST Score is a data-driven signal, not a recommendation.
What are CMMB's factor grades?
Valuation B, Profitability D, Financial Strength B+, Momentum A-, Growth B.
What is CMMB's valuation grade?
Chemomab Therapeutics Ltd. (CMMB) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CMMB's growth grade?
Chemomab Therapeutics Ltd. (CMMB) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CMMB's profitability grade?
Chemomab Therapeutics Ltd. (CMMB) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CMMB's financial strength grade?
Chemomab Therapeutics Ltd. (CMMB) earns a financial strength grade of B+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is CMMB's Piotroski score?
Chemomab Therapeutics Ltd. (CMMB) has a Piotroski F-Score of 0 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.